As GenFleet's co-founder and Chairman of the Board, Dr. Qiang Lu oversees the company's strategic planning, financial management and business operations. With over 20 years of experience in life sciences research and the development of innovative therapies, Dr. Lu boasts extensive expertise across multiple sectors within the industry. Leveraging both practical approaches and strategic foresight, he has successfully advanced numerous products to pivotal clinical and commercial stages.
Dr. Lu holds a doctorate from Brandeis University and completed postdoctoral training at Tufts University. He joined Wyeth and Novartis in America and commanded numerous R&D programs to develop preclinical candidates. Following his overseas career, he served as vice president of WuXi AppTec in China, Chief Scientific Officer of Yangtze River Pharmaceutical Group and Gloria Pharmaceuticals, and senior vice president of CStone Pharmaceuticals. Besides spearheading many compounds into late-stage clinical trials, he also played a major role in operating and promoting multinational R&D platforms.
